Ascend
-12%
est. 2Y upside i
Rank
#2585
Sector
Fintech, InsurTech
Est. Liquidity
~3Y
Data Quality
Data: LowGiven the severe preference overhang and uncertain valuation, the expected 2-year equity upside is -12%, driven by a high probability of bear case where common stock is wiped out.
Last updated: July 19, 2026
IPO window opens and Ascend achieves category leadership, expanding its multiple to 10x forward revenue. Exit value of $400M yields 80% upside net of dilution.
Exit multiple converges to public comp range (7.5x). Exit value of $300M yields 30% upside net of 20% dilution.
Multiple compresses to 5x, exit value of $200M is below $292.6M liquidation preference, common stock recovers 0%, resulting in -100% loss.
Preference Stack Risk
severeFunding Intensity
14630%Total funding of $292.6M far exceeds estimated entry valuation of $200M, creating a 146% liquidation preference overhang that would eliminate common equity in a downside scenario.
Dilution Risk
moderateWhile the latest debt round suggests capital discipline, the company may need to raise equity in 2 years if not profitable, causing ~20% dilution.
Secondary Liquidity
noneNo secondary market observed; any equity sale likely requires a liquidity event.
Questions to Ask at the Interview
Strategic questions based on Ascend's data — designed to show you've done your homework.
- 1
“How does Ascend plan to defend its moat against incumbent insurance AMS providers like Applied Systems?”
- 2
“What are the unit economics (e.g., gross margins, LTV/CAC) and how do they scale?”
- 3
“What is the expected timeline to liquidity (IPO or acquisition) and how does the recent merger affect it?”
Community
Valuation Sentiment
Our model estimates -12% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.